Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients.
暂无分享,去创建一个
J. Birkmeyer | B. Leavitt | J. Morton | E. Olmstead | C. Maloney | L. J. Dacey | E. R. Johnson | L. Dacey | G. T. O'connor | J. Munoz | E. Johnson
[1] G. Mayer,et al. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with Aspirin. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] A. Vuylsteke,et al. Effect of aspirin in coronary artery bypass grafting. , 1997, Journal of cardiothoracic and vascular anesthesia.
[3] D. Reich,et al. Aspirin Does Not Increase Homologous Blood Requirements in Elective Coronary Bypass Surgery , 1994 .
[4] R. E. Clark,et al. Thromboxane A2 receptor-specific antagonism in hypothermic cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.
[5] W. van Oeveren,et al. Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin. , 1993, Journal of Thoracic and Cardiovascular Surgery.
[6] I. Kovács,et al. High‐Dose Aspirin Inhibits Shear‐Induced Platelet Reaction Involving Thrombin Generation , 1992, Circulation.
[7] G. Grover,et al. Thromboxane A2 receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigs. , 1991, The Journal of surgical research.
[8] D. Wheatley,et al. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. , 1990, The Annals of thoracic surgery.
[9] J. Copeland,et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. , 1989, Circulation.
[10] V. Fuster,et al. Aspirin in the prevention of coronary disease. , 1989, The New England journal of medicine.
[11] E. K. Weir,et al. Practical problems in assessing risk for coronary artery bypass grafting. , 1985, The Journal of thoracic and cardiovascular surgery.
[12] V. Fuster,et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. , 1984, The New England journal of medicine.
[13] S Westaby,et al. Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.
[14] F H Edwards,et al. Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. , 1994, The Annals of thoracic surgery.
[15] T. Treasure,et al. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] Thomas E. Moritz,et al. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. , 1990, Journal of the American College of Cardiology.